Repare Therapeutics Inc. Current Assets
Repare Therapeutics Inc. had Current Assets of $124.43 million as of 2025-09-30, per its 10-Q filed 2025-11-14.
Financial Statements › Balance Sheet › Assets › Assets, Current
us-gaap:AssetsCurrent · last filed 2025-11-14
- 2025-09-30: Assets, Current $124.43M.
- 2025-06-30: Assets, Current $126.57M.
- 2025-03-31: Assets, Current $140.34M.
- 2024-12-31: Assets, Current $171.15M.
| Period end | Assets, Current |
|---|---|
| 2025-09-30 | $124.43M 10-Q · filed 2025-11-14 |
| 2025-06-30 | $126.57M 10-Q · filed 2025-08-08 |
| 2025-03-31 | $140.34M 10-Q · filed 2025-05-13 |
| 2024-12-31 | $171.15M 10-Q · filed 2025-11-14 |
| 2024-09-30 | $200.40M 10-Q · filed 2024-11-07 |
| 2024-06-30 | $228.54M 10-Q · filed 2024-08-06 |
| 2024-03-31 | $254.67M 10-Q · filed 2024-05-07 |
| 2023-12-31 | $243.69M 10-K · filed 2025-03-03 |
| 2023-09-30 | $275.09M 10-Q · filed 2023-11-09 |
| 2023-06-30 | $291.93M 10-Q · filed 2023-08-09 |
| 2023-03-31 | $325.53M 10-Q · filed 2023-05-09 |
| 2022-12-31 | $353.98M 10-K · filed 2024-02-28 |
| 2022-09-30 | $390.60M 10-Q · filed 2022-11-09 |
| 2022-06-30 | $289.74M 10-Q · filed 2022-08-04 |
| 2022-03-31 | $319.23M 10-Q · filed 2022-05-05 |
| 2021-12-31 | $351.41M 10-K · filed 2023-02-28 |
| 2021-09-30 | $280.38M 10-Q · filed 2021-11-10 |
| 2021-06-30 | $309.19M 10-Q · filed 2021-08-12 |
| 2021-03-31 | $328.21M 10-Q · filed 2021-05-13 |
| 2020-12-31 | $346.55M 10-K · filed 2022-03-01 |
| 2020-09-30 | $361.26M 10-Q · filed 2020-11-12 |
| 2020-06-30 | $377.26M 10-Q · filed 2020-08-13 |
| 2019-12-31 | $98.57M 10-K · filed 2021-03-04 |